Nasdaq OTC Indices USA Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 7 of 7 Posts
4 Biotech Stocks In Neurology, As Biotechs March On
Article By: Tarun Chandra, CFA Saturday, December 21, 2019 5:20 PM EDT
In a space of 2-months, biotechs have gone from recording yearly lows in early October, to recording 2019 highs.
In this article: NBIX, ACAD, KRTX, NERV
Read
The Week In Charts: Your Trading Success Might All Boil Down To This One Thing
Video By: Dave Landry Sunday, October 7, 2018 7:36 AM EDT
In this episode, Dave discusses how your trading success could boil down to just two words. And, last but not least, he fielded your trading questions and analyzed your favorite stock picks.
In this video: ANET, UROV, MRNS, SQ, TLT, SPY, COMP, IWM, NERV, USO, UUP, XLF
Watch
Minerva Neurosciences Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Wednesday, June 28, 2017 8:53 PM EDT
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $7.75 per share.
In this article: NERV
Read
Minerva Neurosciences Shares Soar On New Amended Agreement With Janssen
Article By: TickerTV Thursday, June 1, 2017 9:16 AM EDT
NERV opened trading yesterday at $8.55 which was exactly the same as the previous day’s trading close. Shares closed trading yesterday at $8.25 and spiked up after market to $9.55, equivalent to a 16% increase from the closing price.
In this article: NERV
Read
Insider Weekends - Edition 314
Article By: Asif Suria Sunday, June 26, 2016 5:01 PM EDT
Insider buying increased last week with insiders buying $124.52 million of stock compared to $81.74 million in the week prior. Selling decreased with insiders selling $462.5 million of stock last week compared to $1.15 billion in the week prior.
In this article: BH, TICC, NERV, LC, PSTG, AAOI, FNF, FB, CELG, DXCM, BKFS
Read
Biotech Rally Fades But Plenty Of Big Movers: ASCO June 6
Article By: Rod Raynovich Saturday, May 28, 2016 6:23 PM EDT
The biotech rally fades after five days with the IBB down 0.49% and XBI down 1%. Biotech stocks were weak at the onset and could not come back but the sector is still up about 7% over five days.
In this article: GSK, ALNY, ARRY, IBB, CELG, XBI, XLV, JUNO, IONS, BMY, RHHBY, NERV, GWPH, ABBV
Read
Minerva Neurosciences Hits An All Time High After A Positive Development
Article By: BioMedReports Tuesday, January 6, 2015 4:27 PM EDT
Compound shows promising results on Parkinson's in primates.
In this article: NERV
Read
1 to 7 of 7 Posts